Skip to main content

System Prediction of Drug-Drug Interactions Through the Integration of Drug Phenotypic, Therapeutic, Structural, and Genomic Similarities

  • Conference paper
  • First Online:
Intelligent Computing Theories and Application (ICIC 2016)

Part of the book series: Lecture Notes in Computer Science ((LNISA,volume 9771))

Included in the following conference series:

  • 1860 Accesses

Abstract

Prediction of drug-drug interactions (DDIs) is an essential step in both drug development and clinical application. As the number of approved drugs increases, the number of potential DDIs rapidly rises. Several drugs have been withdrawn from the market due to DDI-related adverse drug reactions recently. Therefore, it is necessary to develop an accurate prediction tool that can identify potential DDIs during clinical trials. We propose a new methodology for DDIs prediction by integrating the drug-drug pair similarity, including drug phenotypic, therapeutic, structural, and genomic similarity. A large-scale study was conducted to predict 6946 known DDIs of 721 approved drugs. The area under the receiver operating characteristic curve of the integrated models is 0.953 as evaluated using five-fold cross-validation. Additionally, the integrated model is able to detect the biological effect produced by the DDI. Through the integration of drug phenotypic, therapeutic, structural, and genomic similarities, we demonstrated that the proposed method is simple, efficient, allows the uncovering DDIs in the drug development process and postmarketing surveillance.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Beijnen, J.H., Schellens, J.H.: Drug interactions in oncology. Lancet Oncol. 5, 489–496 (2004)

    Article  Google Scholar 

  2. Nemeroff, C.B., Preskorn, S.H., Devane, C.L.: Antidepressant drug-drug interactions: clinical relevance and risk management. CNS Spectr. 12, 1–13 (2007)

    Google Scholar 

  3. Classen, D.C., Pestotnik, S.L., Evans, R.S., Lloyd, J.F., Burke, J.P.: Adverse drug events in hospitalized patientsExcess length of stay, extra costs, and attributable mortality. JAMA 277, 301–306 (1997)

    Article  Google Scholar 

  4. Gottlieb, S.: Antihistamine drug withdrawn by manufacturer. BMJ. Br. Med. J. 319, 7 (1999)

    Article  Google Scholar 

  5. Henney, J.E.: Withdrawal of troglitazone and cisapride. JAMA, J. Am. Med. Assoc. 283, 2228 (2000)

    Article  Google Scholar 

  6. SoRelle, R.: Withdrawal of Posicor from market. Circulation 98, 831–832 (1998)

    Article  Google Scholar 

  7. Moore, T.J., Cohen, M.R., Furberg, C.D.: Serious adverse drug events reported to the food and drug administration, 1998–2005. Arch. Intern. Med. 167, 1752–1759 (2007)

    Article  Google Scholar 

  8. Bjornsson, T.D., Callaghan, J.T., Einolf, H.J., Fischer, V., Gan, L., et al.: The conduct of in vitro and in vivo drug-drug interaction studies: a pharmaceutical research and manufacturers of America (PhRMA) perspective. Drug Metab. Dispos. 31, 815–832 (2003)

    Article  Google Scholar 

  9. http://www.fda.gov

  10. Cheng, F., Li, W., Liu, G., Tang, Y.: In silico ADMET prediction: recent advances, current challenges and future trends. Curr. Top. Med. Chem. 13, 1273–1289 (2013)

    Article  Google Scholar 

  11. Percha, B., Altman, R.B.: Informatics confronts drug–drug interactions. Trends Pharmacol. Sci. 34, 178–184 (2013)

    Article  Google Scholar 

  12. Gottlieb, A., Stein, G.Y., Oron, Y., Ruppin, E., Sharan, R.: INDI: a computational framework for inferring drug interactions and their associated recommendations. Mol. Syst. Biol. 8, 592 (2012)

    Article  Google Scholar 

  13. Huang, J., Niu, C., Green, C.D., Yang, L., Mei, H., et al.: Systematic prediction of pharmacodynamic drug-drug interactions through protein-protein-interaction network. PLoS Comput. Biol. 9, e1002998 (2013)

    Article  Google Scholar 

  14. Cami, A., Manzi, S., Arnold, A., Reis, B.Y.: Pharmacointeraction network models predict unknown drug-drug interactions. PLoS ONE 8, e61468 (2013)

    Article  Google Scholar 

  15. Cheng, F., Zhao, Z.: Machine learning-based prediction of drug–drug interactions by integrating drug phenotypic, therapeutic, chemical, and genomic properties. J. Am. Med. Inform. Assoc. 21, e278–e286 (2014)

    Article  Google Scholar 

  16. Vilar, S., Harpaz, R, Uriarte, E., Santana, L., Rabadan., R., et al.: Drug–drug interaction through molecular structure similarity analysis. J. Am. Med. Inform. Assoc. (2012). doi:10.1136/amiajnl-2012-000935

    Google Scholar 

  17. Wishart, D.S., Knox, C., Guo, A.C., et al.: DrugBank: a knowledgebase for drugs, drug actions and drug targets. Nucl. Acids Res. 36(suppl 1), D901–D906 (2008)

    Google Scholar 

  18. Knox, C., Law, V., Jewison, T., Liu, P., Ly, S., et al.: DrugBank 3.0: a comprehensive resource for ‘omics’ research on drugs. Nucl. Acids Res. 39, D1035–D1041 (2011)

    Article  Google Scholar 

  19. OLBoyle, N.M., Banck, M., James, C.A., Morley, C., Vandermeersch, T., et al.: Open babel: an open chemical toolbox. J. Cheminf. 3, 33 (2011)

    Article  Google Scholar 

  20. Cheng, F., Li, W., Wu, Z., Wang, X., Zhang, C., et al.: Prediction of polypharmacological profiles of drugs by the integration of chemical, side effect, and therapeutic space. J. Chem. Inf. Model. 53, 753–762 (2013)

    Article  Google Scholar 

  21. Xu, K.-J., Song, J., Zhao, X.-M.: The drug cocktail network. BMC Syst. Biol. 6, S5 (2012)

    Article  Google Scholar 

  22. Zhu, F., Shi, Z., Qin, C., Tao, L., Liu, X., et al.: Therapeutic target database update 2012: a resource for facilitating target-oriented drug discovery. Nucl. Acids Res. 40, D1128–D1136 (2012)

    Article  Google Scholar 

  23. Willett, P.: Similarity-based virtual screening using 2D fingerprints. Drug Discov. Today 11, 1046–1053 (2006)

    Article  Google Scholar 

  24. Vilar, S., Karpiak, J., Costanzi, S.: Ligand and structure-based models for the prediction of ligand-receptor affinities and virtual screenings: development and application to the β2-adrenergic receptor. J. Comput. Chem. 31, 707–720 (2010)

    Google Scholar 

  25. Engel, S., Skoumbourdis, A.P., Childress, J., Neumann, S., Deschamps, J.R., et al.: A virtual screen for diverse ligands: discovery of selective G protein-coupled receptor antagonists. J. Am. Chem. Soc. 130, 5115–5123 (2008)

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Chun-Hou Zheng .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this paper

Cite this paper

Wang, B., Yu, X., Wei, R., Yuan, C., Li, X., Zheng, CH. (2016). System Prediction of Drug-Drug Interactions Through the Integration of Drug Phenotypic, Therapeutic, Structural, and Genomic Similarities. In: Huang, DS., Bevilacqua, V., Premaratne, P. (eds) Intelligent Computing Theories and Application. ICIC 2016. Lecture Notes in Computer Science(), vol 9771. Springer, Cham. https://doi.org/10.1007/978-3-319-42291-6_37

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-42291-6_37

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-42290-9

  • Online ISBN: 978-3-319-42291-6

  • eBook Packages: Computer ScienceComputer Science (R0)

Publish with us

Policies and ethics